203 related articles for article (PubMed ID: 22444598)
1. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.
Fu X; Wan S; Hann HW; Myers RE; Hann RS; Au J; Chen B; Xing J; Yang H
Eur J Cancer; 2012 May; 48(7):1014-22. PubMed ID: 22444598
[TBL] [Abstract][Full Text] [Related]
2. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.
Wan S; Hann HW; Ye Z; Hann RS; Lai Y; Wang C; Li L; Myers RE; Li B; Xing J; Yang H
Carcinogenesis; 2017 Apr; 38(4):439-446. PubMed ID: 28334112
[TBL] [Abstract][Full Text] [Related]
3. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis.
Wan S; Hann HW; Myers RE; Fu X; Hann RS; Kim SH; Tang H; Xing J; Yang H
Liver Int; 2012 Sep; 32(8):1233-41. PubMed ID: 22471856
[TBL] [Abstract][Full Text] [Related]
4. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
5. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis.
Liu J; Yang Y; Zhang H; Zhao S; Liu H; Ge N; Yang H; Xing JL; Chen Z
Cancer; 2011 Sep; 117(18):4247-56. PubMed ID: 21387275
[TBL] [Abstract][Full Text] [Related]
6. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection.
Li L; Hann HW; Wan S; Hann RS; Wang C; Lai Y; Ye X; Evans A; Myers RE; Ye Z; Li B; Xing J; Yang H
Sci Rep; 2016 Apr; 6():23992. PubMed ID: 27063412
[TBL] [Abstract][Full Text] [Related]
7. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
8. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Hann HW; Wan S; Lai Y; Hann RS; Myers RE; Patel F; Zhang K; Ye Z; Wang C; Yang H
J Gastroenterol Hepatol; 2015 Jan; 30(1):131-138. PubMed ID: 24995497
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Liu HQ; An JZ; Liu J; Yang YF; Zhang HX; Zhao BY; Li JB; Yang HS; Chen ZN; Xing JL
Carcinogenesis; 2012 May; 33(5):1040-5. PubMed ID: 22318909
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients.
Chen S; Jia J; Gao Y; Li H; Fang M; Feng H; Guan W; Ji J; Gao Z; Gao C
Clin Chim Acta; 2018 Nov; 486():237-244. PubMed ID: 30025756
[TBL] [Abstract][Full Text] [Related]
11. Aflatoxin B
Chu YJ; Yang HI; Wu HC; Liu J; Wang LY; Lu SN; Lee MH; Jen CL; You SL; Santella RM; Chen CJ
Int J Cancer; 2017 Aug; 141(4):711-720. PubMed ID: 28509392
[TBL] [Abstract][Full Text] [Related]
12. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
13. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
14. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
15. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Yu CH; Yu JH; Liu L; Xie SS; Li WW; Yang X; Fan WB; Gai ZT; Chen SJ; Kato N
PLoS One; 2012; 7(1):e29928. PubMed ID: 22235351
[TBL] [Abstract][Full Text] [Related]
16. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
17. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
Kim GA; Han S; Choi GH; Choi J; Lim YS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
[TBL] [Abstract][Full Text] [Related]
18. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
19. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
Li L; Guo Z; Wang J; Mao Y; Gao Q
Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
